1. Home
  2. PVLA vs CFFI Comparison

PVLA vs CFFI Comparison

Compare PVLA & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • CFFI
  • Stock Information
  • Founded
  • PVLA 2015
  • CFFI 1927
  • Country
  • PVLA United States
  • CFFI United States
  • Employees
  • PVLA N/A
  • CFFI N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • CFFI Major Banks
  • Sector
  • PVLA Health Care
  • CFFI Finance
  • Exchange
  • PVLA Nasdaq
  • CFFI Nasdaq
  • Market Cap
  • PVLA 249.2M
  • CFFI 211.9M
  • IPO Year
  • PVLA N/A
  • CFFI 1998
  • Fundamental
  • Price
  • PVLA $25.92
  • CFFI $65.32
  • Analyst Decision
  • PVLA Strong Buy
  • CFFI
  • Analyst Count
  • PVLA 7
  • CFFI 0
  • Target Price
  • PVLA $46.29
  • CFFI N/A
  • AVG Volume (30 Days)
  • PVLA 129.2K
  • CFFI 39.4K
  • Earning Date
  • PVLA 08-15-2025
  • CFFI 07-23-2025
  • Dividend Yield
  • PVLA N/A
  • CFFI 2.76%
  • EPS Growth
  • PVLA N/A
  • CFFI 10.01
  • EPS
  • PVLA N/A
  • CFFI 6.68
  • Revenue
  • PVLA N/A
  • CFFI $116,421,000.00
  • Revenue This Year
  • PVLA N/A
  • CFFI N/A
  • Revenue Next Year
  • PVLA N/A
  • CFFI N/A
  • P/E Ratio
  • PVLA N/A
  • CFFI $9.99
  • Revenue Growth
  • PVLA N/A
  • CFFI 0.67
  • 52 Week Low
  • PVLA $11.17
  • CFFI $44.04
  • 52 Week High
  • PVLA $29.27
  • CFFI $89.90
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • CFFI 58.98
  • Support Level
  • PVLA N/A
  • CFFI $64.85
  • Resistance Level
  • PVLA N/A
  • CFFI $67.75
  • Average True Range (ATR)
  • PVLA 0.00
  • CFFI 2.14
  • MACD
  • PVLA 0.00
  • CFFI 0.75
  • Stochastic Oscillator
  • PVLA 0.00
  • CFFI 86.87

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

Share on Social Networks: